SCHEMBL6964231

SCHEMBL6964231

COc1cccc(Sc2c(O)cc(-c3ccccc3)oc2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 3/20 0.51
ABCG2 Q9UNQ0 3/20 0.47
CYP3A4 P08684 3/20 0.47
MAPT P10636 3/20 0.47
ABCB1 P08183 2/20 0.47
CYP2C9 P11712 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C19 P33261 2/20 0.47
NPC1 O15118 1/20 0.47
TNKS O95271 1/20 0.47
CYP19A1 P11511 1/20 0.47
NTRK1 P04629 1/20 0.46
NTRK2 Q16620 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
USP2 O75604 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7397801 0.85 SMN1; SMN2 (0.54) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL6965057 0.84 SMN1; SMN2 (0.46) CYP3A4MAPTABCB1CYP19A1SMN1; SMN2
SCHEMBL6965119 0.81 SMN1; SMN2 (0.46) CYP3A4MAPTABCB1CYP2C9CYP2C19
SCHEMBL28632329 0.81 ACHE (0.56) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL6958533 0.81 DAO (0.47) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL6958076 0.80 SMN1; SMN2 (0.58) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL6957750 0.80 ABCB1 (0.44) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL7370986 0.80 ABCB1 (0.44) ABCG2CYP3A4MAPTABCB1CYP2C9
SCHEMBL6965164 0.79 ABCG2 (0.45) ABCG2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL6965060 0.78 CYP3A4 (0.46) ABCG2CYP3A4MAPTABCB1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed